New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 9, 2013
06:41 EDTMDCOThe Medicines Co. price target raised to $37 from $34 at Leerink
Leerink raised its price target for The Medicines Co. after the company announced positive Phase 3 results of the PHOENIX trial of Cangrelor. The firm estimates Cangrelor could address a $200M U.S. market opportunity and reiterates an Outperform rating on the stock.
News For MDCO From The Last 14 Days
Check below for free stories on MDCO the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 23, 2014
07:05 EDTMDCOThe Medicines Co. reports Q2 adjusted EPS 31c, may not compare to consensus (2c)
Reports Q2 revenue $183.8M, consensus $183.75M. Reports Q2 unadjusted net loss of (8c).

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use